Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptors
- 17 September 2002
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 955 (1-2) , 138-152
- https://doi.org/10.1016/s0006-8993(02)03396-6
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Parkinson Disease NeuropathologyArchives of Neurology, 2002
- Dopamine agonists: their role in the treatment of Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Anterograde transport of brain-derived neurotrophic factor and its role in the brainNature, 1997
- Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECTPublished by Springer Nature ,1997
- Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]RacloprideMovement Disorders, 1997
- Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's DiseaseArchives of Neurology, 1995
- Which factors predict cognitive decline in Parkinson's disease?Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomographyAnnals of Neurology, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsyEuropean Journal of Pharmacology, 1984